Subject: | |
From: | |
Reply To: | |
Date: | Thu, 8 Dec 2016 08:33:38 -0500 |
Content-Type: | text/plain |
Parts/Attachments: |
|
|
Forward from From co-author: *Bel Townsend* <[log in to unmask]
<mailto:[log in to unmask]>> PHM Australia
Open access article:The Regional Comprehensive Economic Partnership,
Intellectual Property Protection and Access to Medicines
Authors: Belinda Townsend, Deborah Gleeson, and Ruth Lopert.
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2850294
<https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2850294>
Abstract
The inclusion of elevated standards of intellectual property protection
in the recently negotiated Trans Pacific Partnership (TPP) Agreement has
raised serious public health concerns regarding access to medicines. A
lesser-known trade agreement under negotiation in the Asia Pacific
region is the Regional Comprehensive Economic Partnership (RCEP). Framed
as an attempt to reassert ASEAN’s position in response to the United
States-led TPP, RCEP includes key players China and India, as well as
several low and middle-income countries (LMICs). Leaked drafts of
intellectual property provisions proposed by Japan and South Korea raise
similar concerns for access to medicines in the Asia-Pacific region.
This paper identifies TRIPS-Plus provisions in leaked negotiating texts
and examines their implications for those LMICs that are not also
parties to the TPP: Cambodia, Indonesia, Laos, Myanmar, the Philippines,
Thailand, China, and India.
Posted by: Sam Lanfranco
To manage subscriptions/passwords, or view archives, go to http://listserv.yorku.ca/archives/click4hp.html . [log in to unmask] is run in collaboration with Health Nexus: http://www.healthnexus.ca/index_eng.php
|
|
|